Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Figure 1 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
0
Zitationen
20
Autoren
2025
Jahr
Abstract
<p>Specimen selection for GPSai model training and validation. A total of 201,612 non-CUP specimens were used to train the model, 21,106 non-CUP specimens and 443 CUP specimens were used for retrospective validation, 6,820 TCGA cases were used for external validation, and 72,421 non-CUP and 3,850 CUP specimens were used for prospective validation, respectively.</p>
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.988 Zit.
TNM Classification of Malignant Tumours
1987 · 16.123 Zit.
A survey on deep learning in medical image analysis
2017 · 13.698 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.808 Zit.
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
2010 · 9.118 Zit.